Documento fuente o registro público

FDA 510(k) K254194 — QIAstat-Dx BCID GPF Plus AMR Panel

FDA 510(k) index record K254194. Device: QIAstat-Dx BCID GPF Plus AMR Panel. Applicant as listed: QIAGEN GmbH. Decision date: 2026-08-06.

OtherU.S. Food and Drug Administration (FDA)2026-08-06

Fuente

"device_name": "QIAstat-Dx BCID GPF Plus AMR Panel"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-22

Disclaimer

professional use

FDA 510(k) public index record K254194.

Device name: QIAstat-Dx BCID GPF Plus AMR Panel. Applicant as listed: QIAGEN GmbH.

Decision date: 2026-08-06. Decision wording: Substantially Equivalent.

Product code: PAM. Regulation: 21 CFR 866.3365. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más